Systemic side effects have also been reported, including headache, flushing, dizziness, and drowsiness
It is a peptide and an incretin and a dual GIP/GLP1 receptor agonist
More than half of patients prescribed semaglutide or liraglutide for all treatment durations studied were able to maintain or continue their weight loss one year after treatment
Common side effects include nausea, diarrhea, vomiting and constipation, so you should always consult your primary care physician and other trusted health professionals when using GLP-1 treatments
Others escalate to 15 mg
Whatever the category, the structure is the same: platform, independent licensed provider, licensed pharmacy, with prescription at provider discretion